Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.7%. By the end of trading, Boston Scientific rose $0.15 (1.1%) to $13.33 on average volume. Throughout the day, 13,654,898 shares of Boston Scientific exchanged hands as compared to its average daily volume of 11,697,200 shares. The stock ranged in a price between $13.17-$13.50 after having opened the day at $13.19 as compared to the previous trading day's close of $13.18. Other companies within the Health Services industry that increased today were: Globus Medical ( GMED), up 12.1%, Foundation Medicine ( FMI), up 11.8%, InspireMD ( NSPR), up 9.9% and Hooper Holmes ( HH), up 9.4%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $17.3 billion and is part of the health care sector. Shares are up 9.7% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.

On the negative front, Cardica ( CRDC), down 8.3%, Navidea Biopharmaceuticals ( NAVB), down 4.5%, Rosetta Genomics ( ROSG), down 4.4% and Fonar Corporation ( FONR), down 4.3% , were all laggards within the health services industry with Opko Health ( OPK) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers